Mortality and rebleeding following variceal haemorrhage in liver cirrhosis and periportal fibrosis

Table 1 Demographic criteria and clinical presentation in 94 patients with liver cirrhosis and periportal fibrosis presenting with acute variceal haemorrhage n (%)

Variable	PPF (n = 62)	Cirrhosis (n = 32)	P value
Males	56 (90.3)	27 (84.4)	0.395
Females	6 (9.7)	5 (15.6)
Mean age (yr)	49.3 ± 13.4	48.7 ± 15.1	0.840
HBV	4 (6.5)	8 (25)	0.0041
HCV	2 (3.2)	1 (3)
HBV and HCV	0 (0)	3 (9.4)
SBP > 100, PR < 100	50 (80.6)	18 (56.2)	0.0121
SBP < 100, PR > 100	12 (19.4)	14 (43.8)
Hb < 5 g/dL	10 (16.1)	4 (12.5)	0.236
Hb 5-10 g/dL	36 (58.1)	24 (75)
Hb > 10 g/dL	16 (25.8)	4 (12.5)

¹Significant risk factor. HBV: Hepatitis B virus; HCV: Hepatitis C virus; SBP: Systolic blood pressure; PR: Pulse rate; Hb: Haemoglobin.